Adar1-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
198
Total Value
523731625
Accession Number
0001940272-25-000003
Form Type
13F-HR
Manager Name
Adar1-Capital-Management
Data Enrichment
82% identified
163 identified35 unidentified

Holdings

198 positions
Manager:
Search and click to pin securities to the top
Page 9 of 10
G1933S101
Shares:47.4K
Value:$102.4K
CLOVER HEALTH INVESTMENTS, CORP. /DE
Shares:28.3K
Value:$101.6K
Bolt Biotherapeutics, Inc.
Shares:245.0K
Value:$98.0K
Shattuck Labs, Inc.
Shares:102.2K
Value:$97.1K
Upstream Bio, Inc.
Shares:15.0K
Value:$91.8K
Avalo Therapeutics, Inc.
Shares:10.0K
Value:$80.1K
Inozyme Pharma, Inc.
Shares:87.8K
Value:$79.9K
RECURSION PHARMACEUTICALS, INC.
Shares:15.0K
Value:$79.3K
BIOCRYST PHARMACEUTICALS INC
Shares:10.0K
Value:$75.0K
Lyra Therapeutics, Inc.
Shares:533.2K
Value:$67.3K
Phathom Pharmaceuticals, Inc.
Shares:10.1K
Value:$63.3K
Adagio Medical Holdings, Inc.
Shares:76.8K
Value:$61.8K
NextCure, Inc.
Shares:120.0K
Value:$57.6K
Tango Therapeutics, Inc.
Shares:41.3K
Value:$56.6K
Eledon Pharmaceuticals, Inc.
Shares:16.6K
Value:$56.3K
Silence Therapeutics plc
Shares:18.6K
Value:$52.6K
IOVANCE BIOTHERAPEUTICS, INC.
Shares:15.7K
Value:$52.3K
NEKTAR THERAPEUTICS
Shares:67.8K
Value:$46.1K
OnKure Therapeutics, Inc.
Shares:10.0K
Value:$43.0K
Ovid Therapeutics Inc.
Shares:115.9K
Value:$36.1K